Retinal Physician – March 2021
March 2021 The Suprachoroidal Space: New Prospects for Gene Therapy Parisa Emami-Naeini and Glenn…
March 2021 The Suprachoroidal Space: New Prospects for Gene Therapy Parisa Emami-Naeini and Glenn…
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Harrow’s Iheezo, a topical ocular anesthetic, is the first FDA-approved use of chloroprocaine hydrochloride in the US ophthalmic market.
Retinal physicians face increasing pressure from government regulators and payors on various issues. To avoid regulatory scrutiny, it’s vital for practice administrators and owners to…
Studies have shown upregulation of other VEGF subtypes when VEGF-A is blocked. This has led to several companies targeting VEGF-C and VEGF-D to improve outcomes…
“This is the largest annual research budget in our 46-year history,” said Thomas M. Brunner, GRF President and CEO, in a news release.
Long-term results can help guide clinicians’ treatment choices.
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
VEGF-C and VEGF-D are innately involved in the neovascular etiology, so treating that component, in addition to traditional anti-VEGF-A treatment, may have the potential for…
Dr. Tadayoni was well known internationally for his leadership in retinal surgery and ophthalmic education, and he was a revered mentor and friend.